Revvity (NYSE:RVTY) Stock Sale Reported by Rep. Gilbert Ray Cisneros, Jr.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently sold shares of Revvity Inc. (NYSE:RVTY). In a filing disclosed on October 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Revvity stock on September 4th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Benchmark Electronics (NYSE:BHE) on 10/1/2026.
• Sold $1,001 – $15,000 in shares of Oxford Industries (NYSE:OXM) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of Semtech (NASDAQ:SMTC) on 9/29/2026.
• Sold $15,001 – $50,000 in shares of ITT (NYSE:ITT) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of BridgeBio Pharma (NASDAQ:BBIO) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Tandem Diabetes Care (NASDAQ:TNDM) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Cytokinetics (NASDAQ:CYTK) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 9/29/2026.
• Purchased $1,001 – $15,000 in shares of YETI (NYSE:YETI) on 9/29/2026.
• Sold $1,001 – $15,000 in shares of AtriCure (NASDAQ:ATRC) on 9/29/2026.

Revvity Stock Down 1.0%

NYSE RVTY traded down $1.55 on Wednesday, reaching $153.53. The stock had a trading volume of 595,948 shares, compared to its average volume of 1,500,820. Revvity Inc. has a 1 year low of $81.22 and a 1 year high of $166.25. The business has a 50 day moving average price of $134.17 and a 200 day moving average price of $112.19. The company has a current ratio of 1.80, a quick ratio of 1.50 and a debt-to-equity ratio of 0.36. The company has a market capitalization of $17.13 billion, a price-to-earnings ratio of 73.03, a P/E/G ratio of 2.83 and a beta of 1.06.

Revvity (NYSE:RVTY) last released its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The business had revenue of $729.69 million for the quarter, compared to the consensus estimate of $702.96 million. During the same quarter last year, the firm earned $1.18 EPS. Revvity’s revenue for the quarter was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, analysts forecast that Revvity Inc. will post 5.36 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is currently 13.33%.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Wall Street Zen lowered Revvity from a “buy” rating to a “hold” rating in a research note on Sunday, August 16th. Royal Bank Of Canada began coverage on Revvity in a research note on Tuesday, September 1st. They set a “sector perform” rating and a $135.00 price objective for the company. Barclays lifted their price objective on Revvity from $115.00 to $160.00 and gave the company an “equal weight” rating in a report on Wednesday, October 7th. Sanford C. Bernstein assumed coverage on Revvity in a research report on Friday, June 26th. They issued a “market perform” rating and a $115.00 price objective for the company. Finally, Zacks Research raised Revvity from a “strong sell” rating to a “hold” rating in a research note on Tuesday, August 4th. Five analysts have rated the stock with a Buy rating and fourteen have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $124.43.

Hedge Funds Weigh In On Revvity

Hedge funds have recently bought and sold shares of the business. Jupiter Topco LLC purchased a new position in shares of Revvity in the second quarter worth $961,017,000. BlackRock Inc. bought a new position in shares of Revvity in the second quarter worth about $852,070,000. Wellington Management Group LLP lifted its holdings in Revvity by 10,653.8% in the 2nd quarter. Wellington Management Group LLP now owns 865,575 shares of the company’s stock worth $96,304,000 after purchasing an additional 857,526 shares in the last quarter. Primecap Management Co. CA purchased a new stake in shares of Revvity during the 2nd quarter worth approximately $94,921,000. Finally, Bank of America Corp DE bought a new stake in shares of Revvity during the second quarter worth $87,116,000. 86.65% of the stock is owned by institutional investors.

Insider Transactions at Revvity

In other news, insider Tajinder S. Vohra sold 7,330 shares of the stock in a transaction that occurred on Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total transaction of $1,032,650.40. Following the transaction, the insider owned 6,635 shares in the company, valued at $934,738.80. This trade represents a 52.49% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Maxwell Krakowiak sold 1,631 shares of the company’s stock in a transaction that occurred on Monday, September 21st. The shares were sold at an average price of $144.53, for a total value of $235,728.43. Following the completion of the sale, the insider owned 14,781 shares of the company’s stock, valued at $2,136,297.93. This trade represents a 9.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 9,130 shares of company stock worth $1,290,745 in the last 90 days. Insiders own 0.85% of the company’s stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About Revvity

Revvity, Inc (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.